These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Weight gain and first-generation antipsychotics: experience from a developing country. Yoon CK J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660 [No Abstract] [Full Text] [Related]
6. Antipsychotic-induced weight gain in patients with schizophrenia. Llewellyn DJ; Naughton F JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905 [No Abstract] [Full Text] [Related]
7. Schizophrenia, weight gain and atypical antipsychotics. Brown S Br J Psychiatry; 2006 Feb; 188():191-2. PubMed ID: 16449712 [No Abstract] [Full Text] [Related]
8. Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia. Kakunje A; Prabhu A; Priya Es S; Karkal R; Pookoth RK; Pd R J Clin Psychopharmacol; 2018 Dec; 38(6):652-653. PubMed ID: 30192255 [No Abstract] [Full Text] [Related]
9. Antipsychotic drugs: the weight problem. Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878 [No Abstract] [Full Text] [Related]
10. Interventions to reduce weight gain in schizophrenia. Faulkner G; Cohn T; Remington G Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900 [No Abstract] [Full Text] [Related]
11. Is there an anti-fat bias among schizophrenia patients? Pierson KE Obesity (Silver Spring); 2006 Dec; 14(12):2305. PubMed ID: 17189559 [No Abstract] [Full Text] [Related]
12. Weight change with atypical antipsychotics in the treatment of schizophrenia. Haddad P J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334 [TBL] [Abstract][Full Text] [Related]
13. Weight gain, antipsychotic drug treatment and pharmacogenomics. Reynolds GP Pharmacogenomics; 2002 Sep; 3(5):567-70. PubMed ID: 12223042 [No Abstract] [Full Text] [Related]
14. Comparing self-reported ethnicity and structure-determined ethnicity: analysis of antipsychotic-induced weight gain. De Luca V; Monda M; Chan LF Pharmacogenomics; 2013 Dec; 14(16):1943. PubMed ID: 24279847 [No Abstract] [Full Text] [Related]
15. Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Fenton WS; Chavez MR Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676 [No Abstract] [Full Text] [Related]
16. Review of atypical antipsychotics and weight gain. Sussman N J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886 [TBL] [Abstract][Full Text] [Related]
17. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study]. Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804 [No Abstract] [Full Text] [Related]
18. When the heart and the mind collide: cardiovascular risk factors and antipsychotic use in the schizophrenic population. Halpert S; McFarlane SI J Cardiometab Syndr; 2009; 4(1):1-5. PubMed ID: 19245509 [No Abstract] [Full Text] [Related]
19. Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia. Oh N; See YM; Remington G; Lee J J Clin Psychopharmacol; 2016 Aug; 36(4):403-5. PubMed ID: 27187561 [No Abstract] [Full Text] [Related]
20. Antipsychotic-induced weight gain in patients with schizophrenia. Venkatasubramanian G JAMA; 2008 Apr; 299(16):1899; author reply 1899-900. PubMed ID: 18430906 [No Abstract] [Full Text] [Related] [Next] [New Search]